// June 23, 2022
How medicine quality affects antimicrobial resistance and the medicines supply chain ...
Learn how medicine quality affects antimicrobial resistance and the medicines supply chain
Antimicrobial Resistance (AMR)
// April 17, 2023
USP’s Preferential Access for Regulators (PAR) Program: Supporting the Global Supply ...
In the U.S. and around the world, quality standards developed by the U.S. Pharmacopeia (USP) support the availability of safe, quality medicines, regulatory efficiencies, and a strong global medicine supply chain.
// July 11, 2022
USP Convention Series: The supply chain imperative to fight AMR by conserving today’s...
The problem of AMR is likely to have become significantly worse with the reportedly massive inappropriate use of antibiotics over the course of the COVID-19 pandemic, along with the likely increase in the prevalence of poor-quality antimicrobials resulting from supply chain quality concerns.
// May 24, 2022
Supply chain vulnerabilities exist for antimicrobial medicines: USP Medicine Supply M...
Antimicrobial resistance (AMR) is one of the top global health threats. USP's latest analysis shows both an increased risk of shortages for some types of antimicrobials and the geographic concentration of facilities with active Drug Master Files (DMFs) for antimicrobials.
// November 13, 2020
Breeding a superbug: how poor-quality medicines fuel AMR...
Another public health crisis looms in the wake of the COVID-19 pandemic.
